Older women with fractures: patients falling through the cracks of guideline-recommended osteoporosis screening and treatment
- PMID: 14668497
Older women with fractures: patients falling through the cracks of guideline-recommended osteoporosis screening and treatment
Abstract
Background: Many older patients with fractures are not managed in accordance with evidence-based clinical guidelines for osteoporosis. Guidelines recommend that these patients receive treatment for clinically apparent osteoporosis or have bone mineral density measurements followed by treatment when appropriate. This cohort study was conducted to further characterize the gap between guidelines and actual practice with regard to bone mineral density measurement and treatment of older women after a fracture. Our purpose was to aid in the design of more effective future interventions.
Methods: We identified female members of a not-for-profit group-model health maintenance organization who were fifty years of age or older and who had a diagnosis of a new fracture as defined in the study. We used administrative databases and the clinical electronic medical records to obtain data on demographics, diagnoses, drugs dispensed by the pharmacy, and the measurement of bone mineral density.
Results: The study population included 3812 women with an average age of 71.3 years. Fewer than 12% of the women had a diagnosis of osteoporosis prior to the index fracture; 10.7% had an increased risk for secondary osteoporosis and 38.8%, for falls because of a diagnosis or medication. It was found that 46.4% of the study population had been managed as specified by clinical guidelines. The patients who had been managed as specified by the guidelines were younger and less likely to have the risk factor of a weight of <127 lb (58 kg), a hip fracture, or a wrist fracture. They were also more likely to be taking steroids on a chronic basis and to have had a vertebral fracture. The percentage of women who had measurement of bone mineral density increased during the study period, from 1.3% in 1998 to 10.2% in 2001. Of the patients receiving treatment for osteoporosis, 73.6% adhered to the treatment regimen.
Conclusions: Adherence to guidelines for evaluation and treatment for osteoporosis after a patient sustained a fracture did not improve between 1998 and 2001 despite the promulgation of evidence-based guidelines. Methods to enhance education and facilitate processes of care will be necessary to reduce this gap. It may be fruitful to target high-risk subgroups for tailored interventions for prevention of refracture.
Similar articles
-
Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: a gap in evidence-based practice guideline implementation.Arch Intern Med. 2003 Oct 13;163(18):2165-72. doi: 10.1001/archinte.163.18.2165. Arch Intern Med. 2003. PMID: 14557214
-
Bone health in women with premature ovarian insufficiency/early menopause: a 23-year longitudinal analysis.Hum Reprod. 2024 May 2;39(5):1013-1022. doi: 10.1093/humrep/deae037. Hum Reprod. 2024. PMID: 38396142 Free PMC article.
-
Management of osteoporosis in women aged 50 and older with osteoporosis-related fractures in a managed care population.Dis Manag. 2003 Summer;6(2):83-91. doi: 10.1089/109350703321908469. Dis Manag. 2003. PMID: 14577902
-
Osteoporosis screening of postmenopausal women in the primary care setting: a case-based approach.Gend Med. 2004 Dec;1(2):70-85. doi: 10.1016/s1550-8579(04)80013-5. Gend Med. 2004. PMID: 16115586 Review.
-
Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.Postgrad Med. 2010 Jan;122(1):82-90. doi: 10.3810/pgm.2010.01.2102. Postgrad Med. 2010. PMID: 20107292 Review.
Cited by
-
The Orthopedic Upper Extremity Surgeon's Role in the Diagnosis and Treatment of Osteoporosis: Making Use of Opportunistic Imaging.J Clin Med. 2024 Aug 28;13(17):5095. doi: 10.3390/jcm13175095. J Clin Med. 2024. PMID: 39274308 Free PMC article. Review.
-
Design and methods of a postmarketing pharmacoepidemiology study assessing long-term safety of Prolia® (denosumab) for the treatment of postmenopausal osteoporosis.Pharmacoepidemiol Drug Saf. 2013 Oct;22(10):1107-14. doi: 10.1002/pds.3477. Epub 2013 Jul 15. Pharmacoepidemiol Drug Saf. 2013. PMID: 23857864 Free PMC article.
-
Utility of a bone health clinic in bridging the osteoporosis care gap: Prescribing habit review at an academic institution.PLoS One. 2024 Jul 18;19(7):e0307029. doi: 10.1371/journal.pone.0307029. eCollection 2024. PLoS One. 2024. PMID: 39024281 Free PMC article.
-
The knowledge-to-action cycle: identifying the gaps.CMAJ. 2010 Feb 9;182(2):E73-7. doi: 10.1503/cmaj.081231. Epub 2009 Nov 30. CMAJ. 2010. PMID: 19948812 Free PMC article. Review. No abstract available.
-
Challenges in implementing and maintaining osteoporosis therapy.Int J Womens Health. 2014 Aug 13;6:759-69. doi: 10.2147/IJWH.S53489. eCollection 2014. Int J Womens Health. 2014. PMID: 25152632 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous